Torso

AEGEA Medical Completes Enrollment in PACE MX, the Third Study Assessing Long-Term Access to the Uterine Cavity after Endometrial Ablation with Water Vapor

Retrieved on: 
Monday, April 22, 2019
Women, Health, Clinical trials, Medical devices, Consumer, General Health, Torso, Mammal female reproductive system, Pelvis, Medical specialties, Women's health, Medicine, Gynecological surgery, Ablation, Uterus, Endometrium, Heavy menstrual bleeding, Uterine myomectomy

The PACE MX study is the third study of its kind, following the PACE Pilot and PACE II studies.

Key Points: 
  • The PACE MX study is the third study of its kind, following the PACE Pilot and PACE II studies.
  • Furthermore, the PACE studies will evaluate the potential correlation, if any, between ease of long- term access to the uterine cavity and menstrual bleeding status after the water vapor ablation procedure.
  • Ease of long-term hysteroscopic uterine cavity access after endometrial ablation is critical to a womans ongoing clinical care.
  • A Prospective, Multicenter, Pivotal Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor Endometrial Ablation System.

ACEP: Emergency Visits Reach All-Time High

Retrieved on: 
Friday, April 5, 2019
Pain, Health, Torso, Emergency department, Emergency medicine, Chest pain

And, only 4.3 percent of emergency patients went to the emergency department with nonurgent medical symptoms, a decrease from 5.5 percent in 2015.

Key Points: 
  • And, only 4.3 percent of emergency patients went to the emergency department with nonurgent medical symptoms, a decrease from 5.5 percent in 2015.
  • Patients age 15 or younger made up 18.8 percent (27.4 million) of emergency visits.
  • Stomach pain (12.5 million visits, 8.6 percent) and chest pain (7.5 million visits, 5.2 percent) top the list of the most common reasons patients seek emergency care.
  • The leading causes of injury were falls (10.5 million visits, 23 percent of injury visits) and motor vehicle crashes (3.7 million visits, 8.1 percent of total injury visits).

Asia-Pacific Endometrial Ablation Market, 2019: Analysis & Forecast through 2018-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 5, 2019
Surgery, Health, Torso, Mammal female reproductive system, Pelvis, Gynaecology, Gynecological surgery, Women's health, RTT, Medical specialties, Endometrial ablation, Endometrium, Ablation, Vaginal bleeding

The "Asia Pacific Endometrial Ablation Market (2018 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Endometrial Ablation Market (2018 - 2024)" report has been added to ResearchAndMarkets.com's offering.
  • The Asia Pacific Endometrial Ablation Market is expected to witness market growth of 7% CAGR during the forecast period 2018-2024.
  • Endometrial ablation is used in facilitating the destruction of endometrium or thin layer of the uterine wall, and is used in treating abnormal heavy uterine bleeding.
  • Endometrial ablation is a technique that has gained prominence as there is no need for incisions, and the technique is very popular among women suffering menstrual problems.

Kaiser Permanente Improves Emergency Care for Patients With Chest Pain

Retrieved on: 
Wednesday, February 27, 2019
Medicine, Health, Medical specialties, Medical emergencies, Acute pain, Aging-associated diseases, Pain, Torso, Chest pain, Acute coronary syndrome, Emergency department, Emergency medicine

The emergency department assessment was implemented across Kaiser Permanente Southern California and has improved the quality and efficiency of care for these patients according to an article published today in Annals of Emergency Medicine.

Key Points: 
  • The emergency department assessment was implemented across Kaiser Permanente Southern California and has improved the quality and efficiency of care for these patients according to an article published today in Annals of Emergency Medicine.
  • Chest pain -- a symptom that often triggers an evaluation for suspected acute coronary syndrome, or heart attack -- is the second most common reason for emergency department visits.
  • Researchers found that, among patients who went to the emergency department with chest pain, there was:
    A 4.4 percent decrease in hospital admissions and cardiac stress testing after implementation of HEART.
  • Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health.

World Women's Health Therapeutics Market Report 2018-2025: Market Size is Expected to Reach USD 210.9 Billion - Growing Awareness and Introduction of New Drug Therapies

Retrieved on: 
Thursday, November 1, 2018
RTT, Juneau Biosciences, Biocon, Torso, Health, Ovarian cancer, Cancer, Medicine, Endometriosis, Uterus

The women's health therapeutics market is expected to witness high growth in the forthcoming years due to increasing investment by key market players to fulfill demand in areas of infection, cancer, and pregnancy-related complications.

Key Points: 
  • The women's health therapeutics market is expected to witness high growth in the forthcoming years due to increasing investment by key market players to fulfill demand in areas of infection, cancer, and pregnancy-related complications.
  • Juneau Biosciences, LLC has deployed USD 35 million until 2017 towards development of molecular diagnostics and therapeutics for endometriosis (uterus) conditions.
  • In November 2017, Biocon launched KRABEVA, a biosimilar used for the treatment of metastatic colorectal, cervical, ovarian, and brain cancer.
  • Increasing investments by top market players are anticipated to propel the global market over the forecast period.

IMPATHIQ's EPIC integrated Chest pain management tool featured in Circulation publication

Retrieved on: 
Wednesday, October 24, 2018
Perception, Pain, Torso, Medicine, Health, Emergency medicine, Chest pain, Emergency department, Thorax, Chest pain in children

The article "Safely Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge: The HEART Pathway Accelerated Diagnostic Protocol" appeared September 28th in Circulation.

Key Points: 
  • The article "Safely Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge: The HEART Pathway Accelerated Diagnostic Protocol" appeared September 28th in Circulation.
  • This summer, Heart Pathway was successfully installed across the Boston-area Cambridge Health Alliance to streamline chest pain care in its emergency departments, which serve about 100,000 patients a year, strengthening patient care while reducing the number of low-risk chest pain admissions.
  • The Circulation article focused on results from a three-year clinical study of 8,474 adult emergency department patients.
  • "Heart Pathway is the only clinically validated tool available on the EPIC App Orchard store for patients presenting to the ER with chest pain," Dr. Husain said.

Hologic Launches Fluent™ Fluid Management System for Hysteroscopic Procedures

Retrieved on: 
Thursday, August 16, 2018
Medicine, Clinical medicine, Endoscopy, Hysteroscopy, Torso, Uterus, Hologic

MARLBOROUGH, Mass., Aug. 16, 2018 /PRNewswire/ --Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of its new Fluent fluid management system , featuring innovations designed to provide operating room (OR) staff more simplified and effective fluid management for hysteroscopic procedures.

Key Points: 
  • MARLBOROUGH, Mass., Aug. 16, 2018 /PRNewswire/ --Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of its new Fluent fluid management system , featuring innovations designed to provide operating room (OR) staff more simplified and effective fluid management for hysteroscopic procedures.
  • To simplify hysteroscopic operations, the Fluent system features a single waste bag design and unique FloPak technology to effectively control fluid use throughout the procedure.
  • Equipped with an integrated MyoSure controller, the Fluent system can be an all-in-one fluid management and tissue removal system.
  • The Fluent Fluid Management System may not be used to introduce fluids into the uterus when hysteroscopy is contraindicated.

Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Interventional radiology, Medical devices, Torso, Health care, Stent, Interventional cardiology, Renal artery, Common carotid artery, Carotid artery, Drug-eluting stent, Percutaneous coronary intervention

Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Carotid and Renal Artery Stents within the Cardiovascular Devices market.

Key Points: 
  • Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Carotid and Renal Artery Stents within the Cardiovascular Devices market.
  • And Renal Artery Stents are expandable tubes that are implanted to increase the blood flow in the narrowed renal artery.
  • The Carotid and Renal Artery Stents Market is segmented into Renal Artery Bare Metal Stents and Carotid Artery Bare Metal Stents.
  • - Annualized total Carotid and Renal Artery Stents market revenue by segment and market outlooks from 2005-2024.

Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model

Retrieved on: 
Monday, June 4, 2018
Medicine, Interventional radiology, Medical devices, Torso, Health care, Stent, Interventional cardiology, Renal artery, Common carotid artery, Carotid artery, Drug-eluting stent, Percutaneous coronary intervention

Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Carotid and Renal Artery Stents within the Cardiovascular Devices market.

Key Points: 
  • Carotid and Renal Artery Stents - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of Carotid and Renal Artery Stents within the Cardiovascular Devices market.
  • And Renal Artery Stents are expandable tubes that are implanted to increase the blood flow in the narrowed renal artery.
  • The Carotid and Renal Artery Stents Market is segmented into Renal Artery Bare Metal Stents and Carotid Artery Bare Metal Stents.
  • - Annualized total Carotid and Renal Artery Stents market revenue by segment and market outlooks from 2005-2024.